41378-23-8 Usage
Uses
Used in Pharmaceutical Industry:
CHEMBRDG-BB 4024638 is used as a potential therapeutic agent for the treatment of various diseases due to its ability to modulate certain biological pathways and targets. Its potential applications are currently under investigation to better understand its pharmacological properties and efficacy.
Used in Cancer Treatment:
In the field of oncology, CHEMBRDG-BB 4024638 is used as a potential anticancer agent, with its activity in preclinical studies indicating a promising role in the treatment of various types of cancer.
Used in Neurodegenerative Disorder Treatment:
For neurodegenerative conditions, CHEMBRDG-BB 4024638 is used as a potential therapeutic agent, with ongoing research aimed at understanding its impact on the progression of such disorders.
Used in Inflammatory Condition Treatment:
In the context of inflammatory diseases, CHEMBRDG-BB 4024638 is used as a potential anti-inflammatory agent, with its preclinical activity suggesting a role in managing inflammation-related conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 41378-23-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 4,1,3,7 and 8 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 41378-23:
(7*4)+(6*1)+(5*3)+(4*7)+(3*8)+(2*2)+(1*3)=108
108 % 10 = 8
So 41378-23-8 is a valid CAS Registry Number.
InChI:InChI=1/C14H14N2O2/c1-18-13-7-5-10(6-8-13)14(17)16-12-4-2-3-11(15)9-12/h2-9H,15H2,1H3,(H,16,17)
41378-23-8Relevant academic research and scientific papers
ANTI-VIRAL COMPOUNDS
-
Page/Page column 142, (2010/11/27)
Compounds effective in inhibiting replication of Hepatitis C virus ("HCV") or other viruses are disclosed. This invention is also directed to compositions comprising such compounds, co-formulation or co-administration of such compounds with other anti-viral or therapeutic agents, processes and intermediates for the syntheses of such compounds, and methods of using such compounds for the treatment of HCV or other viral infections.
